Global Angioplasty Balloons Market, By Type (Plain Old Balloon Angioplasty, Drug-Coated Balloon (DCB) Angioplasty, Cutting Balloons, Scoring Balloons, Stent Graft Balloon Catheter), Material (Nylon, Polyurethane, Silicone Urethane Co-Polymers, Other), Balloon Type (Semi-Compliant, Non-Compliant), Disease Indication (Coronary Angioplasty, Venous Angioplasty, Carotid Angioplasty, Renal Artery Angioplasty, Peripheral Angioplasty), End User (Cath Labs, Hospitals, Specialty Clinics, Ambulatory Surgery Centers, Diagnostic Centers), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
Market Analysis and Insights of Angioplasty Balloons Market
Data Bridge Market Research analyses that the angioplasty balloons market will exhibit a CAGR of around 4.30% for the forecast period of 2022-2029. Rising prevalence of cardiovascular disorders, increased focus on research and development proficiencies in regards to medical devices and on the adoption of advanced IT healthcare technologies, rising geriatric population base around the globe and rising expenditure for the development of healthcare infrastructure especially in the developing economies are the major factors attributable to the growth of angioplasty balloons market.
Angioplasty refers to a medical surgical procedure that is used to unblock the clogged blood vessels. Angioplasty is a minimally invasive surgical procedure that widens the narrowed or obstructed arteries or veins and treats various disorders as a result of blocked arteries.
Upsurge in the rate of target diseases is one of the major factors fostering the growth of the market. Rising number of applications from the emerging countries is another market growth determinant. Ever- rising technological advancement and innovation of new instruments, surging awareness about the benefits of minimally invasive surgical procedures, rising launch of new innovative products, surging prevalence of coronary and periphery artery diseases in the underdeveloped economies and untapped potential of the emerging markets will further generate lucrative market growth opportunities.
However, lack of awareness in the underdeveloped economies will derail the market growth rate. Also, dearth of skilled medical professionals, high costs associated with the surgical procedure and dearth of a favourable reimbursement scenario in the developing and underdeveloped economies will further pose challenges for the market. Further, rising number of product recalls and clinical risks or complications associated with the surgeries will also hamper the market growth rate.
This angioplasty balloons market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on angioplasty balloons market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Angioplasty Balloons Market Scope and Market Size
The angioplasty balloons market is segmented on the basis of type, material, balloon type, disease indication and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of material, the angioplasty balloons market is segmented into nylon, polyurethane, silicone urethane co-polymers and other.
- On the basis of type, the angioplasty balloons market is segmented into plain old balloon angioplasty, drug-coated balloon (DCB) angioplasty, cutting balloons, scoring balloons, and stent graft balloon catheter.
- On the basis of disease indication, the angioplasty balloons market is segmented into coronary angioplasty, venous angioplasty, carotid angioplasty, renal artery angioplasty and peripheral angioplasty.
- On the basis of end user, the angioplasty balloons market is segmented into cath labs, hospitals, specialty clinics, ambulatory surgery centers and diagnostic centers.
Angioplasty Balloons Market Country Level Analysis
The angioplasty balloons market is segmented on the basis of type, material, balloon type, disease indication and end user.
The countries covered in the angioplasty balloons market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the angioplasty balloons market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the increase in the expenditure for research and development proficiencies, presence of key players in the region and rising prevalence of cardiovascular disorders. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period owing to the increasing government expenditure on healthcare sector, ever-rising geriatric population base and rising personal disposable income.
The country section of the angioplasty balloons market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The angioplasty balloons market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for angioplasty balloons market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the angioplasty balloons. The data is available for historic period 2010 to 2020.
Competitive Landscape and Angioplasty Balloons Market Share Analysis
The angioplasty balloons market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to angioplasty balloons market.
Some of the major players operating in the angioplasty balloons market report are Medtronic, BD, Boston Scientific Corporation, Abbott, AngioDynamics, B. Braun Melsungen AG., Biomerics, BIOTRONIK Vertriebs GmbH & Co. KG, Cook, Cardinal Health, Hexacath, JOTEC GmbH, CTK biotech, Inc, Koninklijke Philips N.V.., MicroPort Scientific Corporation, Nipro Medical Corporation, Palex Medical SA, Panmed US, Stryker, Teleflex Incororated and Terumo Corporation among others.
SKU-
